ATE331521T1 - Behandlung von schmerzen - Google Patents

Behandlung von schmerzen

Info

Publication number: ATE331521T1
Authority: AT; Austria
Prior art keywords: pain; treatment; dopa; antidepressant; neurotransmitters
Prior art date: 1996-08-29

Application number

AT97937721T

Other languages

English (en)

Inventor

David Frederick Horrobin

Cari Loder

Graham Scotia Cooper

Original Assignee

Worsley Andrew Peter

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-29

Filing date

1997-08-27

Publication date

2006-07-15

1997-08-27 Application filed by Worsley Andrew Peter filed Critical Worsley Andrew Peter

2006-07-15 Application granted granted Critical

2006-07-15 Publication of ATE331521T1 publication Critical patent/ATE331521T1/de

Links

QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
229940024606 amino acid Drugs 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
238000011260 co-administration Methods 0.000 abstract 1
239000000411 inducer Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002858 neurotransmitter agent Substances 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
229960004799 tryptophan Drugs 0.000 abstract 1
229960004441 tyrosine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Mechanical Treatment Of Semiconductor (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97937721T 1996-08-29 1997-08-27 Behandlung von schmerzen ATE331521T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9617990.8A GB9617990D0 (en)	1996-08-29	1996-08-29	Treatment of pain

Publications (1)

Publication Number	Publication Date
ATE331521T1 true ATE331521T1 (de)	2006-07-15

Family

ID=10799070

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97937721T ATE331521T1 (de)	1996-08-29	1997-08-27	Behandlung von schmerzen

Country Status (11)

Country	Link
US (2)	US6451788B1 (de)
EP (1)	EP1007053B1 (de)
AT (1)	ATE331521T1 (de)
AU (1)	AU733088B2 (de)
DE (1)	DE69736249T2 (de)
DK (1)	DK1007053T3 (de)
ES (1)	ES2264806T3 (de)
GB (1)	GB9617990D0 (de)
PT (1)	PT1007053E (de)
WO (1)	WO1998008520A1 (de)
ZA (1)	ZA977794B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9617990D0 (en) *	1996-08-29	1996-10-09	Scotia Holdings Plc	Treatment of pain
AU3485999A (en) *	1998-04-10	1999-11-01	Mayo Foundation For Medical Education And Research	Neo-tryptophan
ES2292238T3 (es) *	1998-04-24	2008-03-01	Scarista Limited	Tratamiento de la depresion y preparaciones farmaceuticas para el mismo.
GB9904252D0 (en) *	1999-02-24	1999-04-21	Worsley Andrew P	Composition for the treatment of pain
US6575147B2 (en) *	1999-02-25	2003-06-10	Go-Tec	Internal combustion system adapted for use of a dual fuel composition including acetylene
GB9906808D0 (en) *	1999-03-24	1999-05-19	Kilgowan Limited	Formulation for treatment of pain
US6403657B1 (en) *	1999-10-04	2002-06-11	Martin C. Hinz	Comprehensive pharmacologic therapy for treatment of obesity
US6759437B2 (en) *	1999-10-04	2004-07-06	Martin C. Hinz	Comprehensive pharmacologic therapy for treatment of obesity including cysteine
GB2355191A (en) *	1999-10-12	2001-04-18	Laxdale Ltd	Combination formulations for fatigue, head injury and strokes
GB0216027D0 (en)	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
US6602911B2 (en) *	2001-11-05	2003-08-05	Cypress Bioscience, Inc.	Methods of treating fibromyalgia
CA2475763A1 (en) *	2002-02-12	2003-08-21	Cypress Bioscience, Inc.	Methods of treating attention deficit/hyperactivity disorder (adhd)
US20070293571A1 (en) *	2006-06-08	2007-12-20	Hinz Martin C	Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
EP1490073A4 (de) *	2002-03-21	2006-02-01	Martin C Hinz	Segmentoptimierungstechnik für das serotonin- und catecholamin-system
US20090311795A1 (en) *	2002-03-21	2009-12-17	Hinz Martin C	Bilateral control of functions traditionally regulated by only serotonin or only dopamine
CN1662231A (zh) *	2002-04-24	2005-08-31	柏树生物科学公司	包括应激相关障碍在内的功能性躯体障碍的预防与治疗
CA2484482C (en) *	2002-05-30	2011-07-26	Neurosearch A/S	Triple monoamine reuptake inhibitors for the treatment of chronic pain
US8134029B2 (en) *	2002-09-16	2012-03-13	Sunovion Pharmaceuticals Inc.	Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
EP1558231A4 (de) *	2002-10-03	2010-09-08	Cypress Bioscience Inc	Dosiseskalation und geteilte tagesdosis von antidepressiva zurbehandlung von neurologischen erkrankungen
MXPA05008943A (es) *	2003-02-21	2005-11-08	C Hinz Martin	Tecnologia de optimizacion del segmento de sistema de serotonina y catecolamina.
WO2004105690A2 (en) *	2003-05-23	2004-12-09	Cypress Bioscience, Inc.	Treatment of chronic pain associated with drug or radiation therapy
JP4638685B2 (ja) *	2003-06-10	2011-02-23	ハイデルベルガードルツクマシーネンアクチエンゲゼルシヤフト	オフセット印刷機による印刷の際に湿し水を調量する方法
GB0313630D0 (en) *	2003-06-12	2003-07-16	Wwk Trust The	Compositions for the enhanced treatment of depression
US7442372B2 (en)	2003-08-29	2008-10-28	Biomarin Pharmaceutical Inc.	Delivery of therapeutic compounds to the brain and other tissues
WO2005048926A2 (en)	2003-11-13	2005-06-02	The General Hospital Corporation	Methods for treating pain
PL1708690T3 (pl)	2003-11-17	2017-01-31	Biomarin Pharmaceutical Inc.	Leczenie fenyloketonurii za pomocą BH4
KR20070084270A (ko)	2004-11-17	2007-08-24	바이오마린 파머수티컬 인크.	안정한 정제 제형물
JP2008523090A (ja) *	2004-12-08	2008-07-03	バイオマリンファーマシューティカルインコーポレイテッド	新生児肺高血圧症の治療のための方法および組成物
JP2009500425A (ja)	2005-07-06	2009-01-08	セプラコアインコーポレーテッド	エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
US7750101B2 (en) *	2005-09-28	2010-07-06	Daicel Chemical Industries, Ltd.	Polycyclic ester containing cyano group and lactone skeleton
US7994220B2 (en) *	2005-09-28	2011-08-09	Cypress Bioscience, Inc.	Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2007067570A1 (en) *	2005-12-05	2007-06-14	Biomarin Pharmaceutical Inc.	Methods and compositions for the treatment of disease
US20090306050A1 (en) *	2006-02-03	2009-12-10	Timothy Dinan	Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
WO2007100718A2 (en) *	2006-02-24	2007-09-07	Denise Barbut	Neurotensin receptor agonists and opioid receptor agonists
DK2816024T3 (en)	2006-03-31	2017-10-30	Sunovion Pharmaceuticals Inc	CHIRALE AMINER
AU2007254751A1 (en) *	2006-05-31	2007-12-13	Sepracor Inc.	Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
US20100009997A1 (en) *	2007-01-12	2010-01-14	Biomarin Pharmaceutical Inc.	Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
US20080220104A1 (en) *	2007-03-08	2008-09-11	Cappello John V	Compositions for producing satiety
LT2545939T (lt)	2007-04-11	2021-03-10	Biomarin Pharmaceutical Inc.	Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu
EP2629615B1 (de)	2010-10-22	2018-10-10	Duke University	Retardformulierungen aus 5-hydroxytryptophan als zusatz für pro-serotonergische therapien
JP2014503592A (ja) *	2011-01-26	2014-02-13	ニコワールドワイド，インコーポレイテッド	片頭痛の療法
US9216178B2 (en)	2011-11-02	2015-12-22	Biomarin Pharmaceutical Inc.	Dry blend formulation of tetrahydrobiopterin
ITUB20153879A1 (it) *	2015-09-24	2017-03-24	Professional Dietetics Spa	Composizioni per il trattamento del dolore in pazienti sottoposti ad artroplastica elettiva

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4431670A (en) *	1980-12-19	1984-02-14	Bernardo Heller	D-Phenylalanine treatment
US4652559A (en) *	1982-08-16	1987-03-24	The Upjohn Company	2-(Phenylmethylene)cycloalkyl-azetidines
US4843071A (en) *	1986-12-05	1989-06-27	Serotonin Industries Of Charleston	Method and composition for treating obesity, drug abuse, and narcolepsy
CA2200761C (en) *	1994-10-05	2008-02-26	Cari Loder	Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound
EP0942751B1 (de)	1996-07-05	2002-09-25	The WWK Trust	Zusammensetzungen zur behandlung der peripheren neuropathie, die antidepressiven verbindungen und/oder monoamino-oxidaseinhibitoren und/oder vitamin b12 und/oder neurotransmitter-vorläufer oder induktoren enthalten
GB9617990D0 (en) *	1996-08-29	1996-10-09	Scotia Holdings Plc	Treatment of pain

1996
- 1996-08-29 GB GBGB9617990.8A patent/GB9617990D0/en active Pending
1997
- 1997-08-27 ES ES97937721T patent/ES2264806T3/es not_active Expired - Lifetime
- 1997-08-27 AU AU40253/97A patent/AU733088B2/en not_active Ceased
- 1997-08-27 AT AT97937721T patent/ATE331521T1/de not_active IP Right Cessation
- 1997-08-27 DK DK97937721T patent/DK1007053T3/da active
- 1997-08-27 DE DE69736249T patent/DE69736249T2/de not_active Expired - Lifetime
- 1997-08-27 PT PT97937721T patent/PT1007053E/pt unknown
- 1997-08-27 WO PCT/GB1997/002295 patent/WO1998008520A1/en not_active Ceased
- 1997-08-27 US US09/242,882 patent/US6451788B1/en not_active Expired - Fee Related
- 1997-08-27 EP EP97937721A patent/EP1007053B1/de not_active Expired - Lifetime
- 1997-08-29 ZA ZA9707794A patent/ZA977794B/xx unknown
2002
- 2002-08-07 US US10/213,905 patent/US6989380B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1007053A1 (de)	2000-06-14
AU4025397A (en)	1998-03-19
DE69736249D1 (de)	2006-08-10
EP1007053B1 (de)	2006-06-28
ES2264806T3 (es)	2007-01-16
GB9617990D0 (en)	1996-10-09
AU733088B2 (en)	2001-05-03
US20020187958A1 (en)	2002-12-12
US6989380B2 (en)	2006-01-24
DE69736249T2 (de)	2007-05-24
DK1007053T3 (da)	2006-10-30
US6451788B1 (en)	2002-09-17
WO1998008520A1 (en)	1998-03-05
PT1007053E (pt)	2006-11-30
ZA977794B (en)	1998-04-17

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1007053

Country of ref document: EP

2011-05-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE331521T1 (de)	2006-07-15	Behandlung von schmerzen
DE69616375D1 (de)	2001-11-29	Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen
DK0934061T3 (da)	2003-09-22	Isobutylgaba og dets derivater til behandling af smerte
ATE350030T1 (de)	2007-01-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
TR200000755T2 (tr)	2000-09-21	Karşıt olma-karşı gelme bozukluğunun tedavisi.
DE69634900D1 (de)	2005-08-04	Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
TR199802676A2 (xx)	1999-11-22	T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DE69508192D1 (de)	1999-04-15	Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DE69929464D1 (de)	2006-04-06	Zyklische polyamine zur behandlung der thrombozytopenie
CA2304657A1 (en)	1999-04-01	Treatment of conduct disorder
RU94022017A (ru)	1996-08-27	Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
DE69715000D1 (de)	2002-10-02	Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
TR200101149T2 (tr)	2001-10-22	Dış retina bozukluklarının tedavisi.
DE60210101D1 (de)	2006-05-11	Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten
DE69523324D1 (de)	2001-11-22	Behandlung von Angstzuständen
DE69912743D1 (de)	2003-12-18	Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
DE69808475D1 (de)	2002-11-07	Aminosäurederivate zur behandlung von schlaganfall
DE69626816D1 (de)	2003-04-24	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE261724T1 (de)	2004-04-15	Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
DE69735417D1 (de)	2006-05-04	2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
PT950056E (pt)	2002-12-31	N-(piridinilamino) isoindolinas e compostos relacionados
DE69806062D1 (de)	2002-07-18	Kombinationstherapie zur behandlung von aids
DK0968174T3 (da)	2003-05-12	Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
BR0112460A (pt)	2003-07-22	Método para tratamento de sépsis